• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度高苯丙氨酸血症女性的妊娠经历。

Pregnancy experiences in the woman with mild hyperphenylalaninemia.

作者信息

Levy Harvey L, Waisbren Susan E, Güttler Flemming, Hanley William B, Matalon Reuben, Rouse Bobbye, Trefz Friedrich K, de la Cruz Felix, Azen Colleen G, Koch Richard

机构信息

Division of Genetics, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

出版信息

Pediatrics. 2003 Dec;112(6 Pt 2):1548-52.

PMID:14654663
Abstract

OBJECTIVE

A major issue in maternal phenylketonuria (MPKU) has been whether maternal non-PKU mild hyperphenylalaninemia (MHP) is teratogenic. Such untreated pregnancies and their outcomes are presented on this report.

METHODS

Enrolled pregnancies in which the untreated prepregnancy assigned phenylalanine level (APL) was no more than 600 micro mol/L were included in the Maternal PKU Collaborative Study and were followed according to protocol.

RESULTS

Forty-eight enrolled women with non-PKU MHP had mean APL 408 +/- 114 micromol/L. They had a total of 58 pregnancies that resulted in live births. Fifty were untreated. Maternal phenylalanine (Phe) levels in the untreated pregnancies decreased during pregnancy for average Phe exposure of 270 +/- 84 micromol/L, virtually identical to the level of 269 +/- 136 micromol/L in the 8 treated pregnancies. Birth measurements in the 50 offspring from untreated pregnancies were within normal limits with z scores of -0.25 for weight, 0.28 for length, and -0.63 for head circumference, although birth head circumference was negatively correlated with maternal APL (r = -0.30). Only 1 offspring had congenital heart disease. Offspring IQ was 102 +/- 15 compared with 96 +/- 14 in the mothers with untreated pregnancies and with 109 +/- 21 in control offspring.

CONCLUSION

Maternal non-PKU MHP no more than 600 micromol/L does not require dietary therapy. The naturally lower Phe level during pregnancy seems to protect against teratogenesis.

摘要

目的

母体苯丙酮尿症(MPKU)中的一个主要问题一直是母体非苯丙酮尿症轻度高苯丙氨酸血症(MHP)是否具有致畸性。本报告展示了此类未经治疗的妊娠及其结局。

方法

母体苯丙酮尿症协作研究纳入了孕前未治疗时指定苯丙氨酸水平(APL)不超过600微摩尔/升的妊娠,并按照方案进行随访。

结果

48名纳入研究的患有非苯丙酮尿症MHP的女性,平均APL为408±114微摩尔/升。她们共有58次妊娠并分娩出活产婴儿。其中50次妊娠未经治疗。未经治疗的妊娠中母体苯丙氨酸(Phe)水平在孕期下降,平均Phe暴露量为270±84微摩尔/升,与8次经治疗妊娠中的269±136微摩尔/升水平几乎相同。未经治疗妊娠的50名后代的出生测量值在正常范围内,体重的z评分为-0.25,身长为0.28,头围为-0.63,尽管出生头围与母体APL呈负相关(r = -0.30)。只有1名后代患有先天性心脏病。后代智商为102±15,与之相比,未经治疗妊娠的母亲智商为96±14,对照后代智商为109±21。

结论

母体非苯丙酮尿症MHP不超过600微摩尔/升不需要饮食治疗。孕期自然较低的Phe水平似乎可预防致畸作用。

相似文献

1
Pregnancy experiences in the woman with mild hyperphenylalaninemia.轻度高苯丙氨酸血症女性的妊娠经历。
Pediatrics. 2003 Dec;112(6 Pt 2):1548-52.
2
Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.苯丙氨酸羟化酶基因对母体苯丙酮尿症结局的影响。
Pediatrics. 2003 Dec;112(6 Pt 2):1530-3.
3
Role of nutrition in pregnancy with phenylketonuria and birth defects.营养在苯丙酮尿症妊娠及出生缺陷中的作用。
Pediatrics. 2003 Dec;112(6 Pt 2):1534-6.
4
Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.四氢生物蝶呤在治疗母体苯丙酮尿症中的潜在作用。
Pediatrics. 2003 Dec;112(6 Pt 2):1566-9.
5
Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.母体苯丙酮尿症和高苯丙氨酸血症。未经治疗和经治疗妊娠结局的国际调查。
N Engl J Med. 1980 Nov 20;303(21):1202-8. doi: 10.1056/NEJM198011203032104.
6
The Maternal Phenylketonuria International Study: 1984-2002.国际母婴苯丙酮尿症研究:1984 - 2002年
Pediatrics. 2003 Dec;112(6 Pt 2):1523-9.
7
[The maternal phenylketonuria syndrom--still current problem].[母体苯丙酮尿症综合征——仍然是当前的问题]
Przegl Lek. 2009;66(1-2):4-10.
8
Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.产前苯丙氨酸暴露与婴幼儿及儿童认知结局的关系:国际母源性苯丙酮尿症协作研究结果
Pediatrics. 2003 Dec;112(6 Pt 2):1537-43.
9
Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.未经治疗的母体苯丙酮尿症和高苯丙氨酸血症对胎儿的影响。
N Engl J Med. 1983 Nov 24;309(21):1269-74. doi: 10.1056/NEJM198311243092101.
10
Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy.孕期母体高苯丙氨酸水平对4岁和6岁子代先天性异常及发育结局的影响:孕前及整个孕期严格饮食控制的重要性
J Pediatr. 2004 Feb;144(2):235-9. doi: 10.1016/j.jpeds.2003.10.062.

引用本文的文献

1
Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.土耳其母体苯丙酮尿症:71 例妊娠结局及处理要点。
Eur J Pediatr. 2019 Jul;178(7):1005-1011. doi: 10.1007/s00431-019-03387-8. Epub 2019 May 3.
2
The complete European guidelines on phenylketonuria: diagnosis and treatment.《苯丙酮尿症的完整欧洲指南:诊断与治疗》。
Orphanet J Rare Dis. 2017 Oct 12;12(1):162. doi: 10.1186/s13023-017-0685-2.
3
Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics.
母体苯丙酮尿症:子代的长期结局及产后母体特征
JIMD Rep. 2015;21:23-33. doi: 10.1007/8904_2014_365. Epub 2015 Feb 25.
4
Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases.盐酸沙丙蝶呤在母体苯丙酮尿症中的应用。欧洲8例病例的经验。
J Inherit Metab Dis. 2014 Sep;37(5):753-62. doi: 10.1007/s10545-014-9716-5. Epub 2014 May 1.
5
Maternal hyperphenylalaninemia: rapid achievement of metabolic control predicts overall control throughout pregnancy.母体高苯丙氨酸血症:快速达到代谢控制可预测整个孕期的总体控制情况。
Mol Genet Metab. 2013 May;109(1):3-8. doi: 10.1016/j.ymgme.2013.02.009. Epub 2013 Feb 19.
6
Up to date knowledge on different treatment strategies for phenylketonuria.关于苯丙酮尿症不同治疗策略的最新知识。
Mol Genet Metab. 2011;104 Suppl(0):S19-25. doi: 10.1016/j.ymgme.2011.08.009. Epub 2011 Aug 16.
7
Advances and challenges in phenylketonuria.苯丙酮尿症的进展与挑战
J Inherit Metab Dis. 2010 Dec;33(6):645-8. doi: 10.1007/s10545-010-9247-7.
8
Cell encapsulation as a potential nondietary therapy for maternal phenylketonuria.细胞封装作为一种潜在的非饮食疗法用于治疗母体苯丙酮尿症。
Am J Obstet Gynecol. 2009 Sep;201(3):289.e1-6. doi: 10.1016/j.ajog.2009.05.035. Epub 2009 Jul 24.
9
Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'.母体苯丙酮尿症协作研究(MPKUCS)——“异常值”。
J Inherit Metab Dis. 2004;27(6):711-23. doi: 10.1023/B:BOLI.0000045758.86492.54.
10
Maternal histidinaemia: pregnancies and offspring outcomes.母体组氨酸血症:妊娠情况及子代结局
J Inherit Metab Dis. 2004;27(2):197-204. doi: 10.1023/B:BOLI.0000028783.35805.dd.